Howard Mayer
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 9
- HIV Research and Treatment 9
-
- Clostridium difficile and Clostridium perfringens research 2
- HIV/AIDS Research and Interventions 1
- HIV/AIDS drug development and treatment 1
- Co-authors
- James Goodrich (8 shared papers)Elna van der Ryst (4 shared papers)Bonaventura Clotet (2 shared papers)Nathan Clumeck (2 shared papers)John F. Sullivan (2 shared papers)Julie Passarell (1 shared paper)Paul G. Ambrose (1 shared paper)Dennis M. Grasela (1 shared paper)
- Journals
- The Journal of Infectious Diseases (4 papers)AIDS (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)HIV Clinical Trials (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Howard Mayer
15 papers receiving 1.6k citations
Howard Mayer's Hit Papers
Peers
Comparison fields: 5 of 79
- Virology 989
- Infectious Diseases 710
- Molecular Medicine 109
- Applied Microbiology and Biotechnology 33
- Pharmacology 215
Countries citing papers authored by Howard Mayer
This map shows the geographic impact of Howard Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Mayer more than expected).
Fields of papers citing papers by Howard Mayer
This network shows the impact of papers produced by Howard Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Mayer. The network helps show where Howard Mayer may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard Mayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Maraviroc for Previously Treated Patients with R5 HIV-1 Infection Hit paper breakdown → | 2008 | 572 |
| 2 | 2001 | 239 | |
| 3 | 2005 | 223 | |
| 4 | 2005 | 169 | |
| 5 | 2009 | 109 | |
| 6 | 2010 | 72 | |
| 7 | 2010 | 60 | |
| 8 | 2012 | 51 | |
| 9 | 2010 | 49 | |
| 10 | 1994 | 42 | |
| 11 | 1998 | 41 | |
| 12 | 2010 | 39 | |
| 13 | 2010 | 12 | |
| 14 | 2010 | 1 | |
| 15 | 1980 | 1 |
About Howard Mayer
Howard Mayer is a scholar working on Virology, Infectious Diseases, Epidemiology, Molecular Biology and Pharmacology, having authored 15 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), Clostridium difficile and Clostridium perfringens research (2 papers), HIV/AIDS Research and Interventions (1 paper), HIV/AIDS drug development and treatment (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Escherichia coli research studies (1 paper), Microscopic Colitis (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Virology (989 citations), Infectious Diseases (710 citations), Molecular Medicine (109 citations), Applied Microbiology and Biotechnology (33 citations) and Pharmacology (215 citations). Howard Mayer has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include James Goodrich, Elna van der Ryst, Bonaventura Clotet, Nathan Clumeck, John F. Sullivan, Julie Passarell, Paul G. Ambrose, Dennis M. Grasela, Phillip F. Pierce and Thaddeus H. Grasela. Their work appears in journals such as The Journal of Infectious Diseases, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, HIV Clinical Trials and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.